HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,279,890 | +2.3% | 112,039 | -3.4% | 0.04% | +7.7% |
| Q2 2023 | $4,182,028 | -9.7% | 115,942 | -4.4% | 0.04% | -15.2% |
| Q1 2023 | $4,630,881 | +89437.5% | 121,259 | +33.4% | 0.05% | -41.0% |
| Q4 2022 | $5,172 | -99.9% | 90,902 | -8.3% | 0.08% | +23.8% |
| Q3 2022 | $3,918,000 | -11.0% | 99,089 | -0.9% | 0.06% | -10.0% |
| Q2 2022 | $4,402,000 | +10.6% | 100,039 | +0.2% | 0.07% | +29.6% |
| Q1 2022 | $3,980,000 | -2.5% | 99,811 | -1.7% | 0.05% | +8.0% |
| Q4 2021 | $4,081,000 | -4.7% | 101,496 | -3.6% | 0.05% | -5.7% |
| Q3 2021 | $4,283,000 | -5.4% | 105,290 | +5.6% | 0.05% | 0.0% |
| Q2 2021 | $4,529,000 | +14.3% | 99,743 | +5.0% | 0.05% | +8.2% |
| Q1 2021 | $3,961,000 | -9.1% | 95,000 | -6.9% | 0.05% | -10.9% |
| Q4 2020 | $4,358,000 | – | 102,033 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |